Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M3PG
|
||||
Former ID |
DNC005894
|
||||
Drug Name |
6,7-dihydroxy-8-nitro-1-tetralone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C10H9NO5
|
||||
Canonical SMILES |
C1CC2=CC(=C(C(=C2C(=O)C1)[N+](=O)[O-])O)O
|
||||
InChI |
1S/C10H9NO5/c12-6-3-1-2-5-4-7(13)10(14)9(8(5)6)11(15)16/h4,13-14H,1-3H2
|
||||
InChIKey |
CXOQHHVPOJWTNP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Catechol-O-methyl-transferase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | L-dopa degradation | ||||
Dopamine degradation | |||||
Noradrenaline and adrenaline degradation | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Tyrosine metabolism | |||||
Metabolic pathways | |||||
Dopaminergic synapse | |||||
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Tyrosine Metabolism | ||||
WikiPathways | Methylation Pathways | ||||
Metapathway biotransformation | |||||
Estrogen metabolism | |||||
Biogenic Amine Synthesis | |||||
Dopamine metabolism | |||||
Phase II conjugation | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References | |||||
REF 1 | J Med Chem. 2005 Dec 15;48(25):8070-8.Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferase. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.